Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
cytokine induced killer cells (1 trial)
Adenocarcinoma (Phase 2)
Adenocarcinoma of Lung (Phase 2)
Trials (1 total)
Trial APIs (1 total)